SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Amy M. Jimenez, Junghee Lee, Jonathan K. Wynn, Mark S. Cohen, Stephen A. Engel, David C. Glahn, Keith H. Nuechterlein, Eric A. Reavis, Michael F. Green, Abnormal Ventral and Dorsal Attention Network Activity during Single and Dual Target Detection in Schizophrenia, Frontiers in Psychology, 2016, 7,

    CrossRef

  2. 2
    Yavuz Ayhan, Ross McFarland, Mikhail V. Pletnikov, Animal models of gene–environment interaction in schizophrenia: A dimensional perspective, Progress in Neurobiology, 2016, 136, 1

    CrossRef

  3. 3
    Bernard Crespi, Emma Leach, Natalie Dinsdale, Mikael Mokkonen, Peter Hurd, Imagination in human social cognition, autism, and psychotic-affective conditions, Cognition, 2016, 150, 181

    CrossRef

  4. 4
    R. Upthegrove, M. R. Broome, K. Caldwell, J. Ives, F. Oyebode, S. J. Wood, Understanding auditory verbal hallucinations: a systematic review of current evidence, Acta Psychiatrica Scandinavica, 2016, 133, 5
  5. 5
    Roland Imhoff, Zeroing in on the Effect of the Schizophrenia Label on Stigmatizing Attitudes: A Large-scale Study, Schizophrenia Bulletin, 2016, 42, 2, 456

    CrossRef

  6. 6
    Katarzyna Stebelska, Krzysztof Łabuz, Neuropathology of Drug Addictions and Substance Misuse, 2016,

    CrossRef

  7. 7
    Michael J. Flexer, “[L]abels of Themselves Condition Our Perceptions”: The DSM and the Diagnostic Sign of Schizophrenia, Sociology Compass, 2015, 9, 1
  8. 8
    Lucy Albertella, Mike E. Le Pelley, Jan Copeland, Cannabis use, schizotypy, and negative priming, Psychiatry Research, 2015, 228, 3, 404

    CrossRef

  9. 9
    Bernard J. Crespi, Matthew C. Go, Diametrical diseases reflect evolutionary-genetic tradeoffs, Evolution, Medicine, and Public Health, 2015, 2015, 1, 216

    CrossRef

  10. 10
    Eyal Zvi Shamir, Anat Levy, Stanley Morris Cassan, Tova Lifshitz, Gaby Shefler, Ricardo Tarrasch, Do biometric parameters of the hand differentiate schizophrenia from other psychiatric disorders? A comparative evaluation using three mental health modules, Psychiatry Research, 2015, 228, 3, 425

    CrossRef

  11. 11
    D. Bhugra, N. Sartorius, A. Fiorillo, S. Evans-Lacko, A. Ventriglio, M.H.M. Hermans, P. Vallon, J. Dales, G. Racetovic, J. Samochowiec, M. Roca Bennemar, T. Becker, T. Kurimay, W. Gaebel, EPA guidance on how to improve the image of psychiatry and of the psychiatrist, European Psychiatry, 2015, 30, 3, 423

    CrossRef

  12. 12
    Björn H. Schott, Martin Voss, Benjamin Wagner, Torsten Wüstenberg, Emrah Düzel, Joachim Behr, Fronto-limbic novelty processing in acute psychosis: disrupted relationship with memory performance and potential implications for delusions, Frontiers in Behavioral Neuroscience, 2015, 9,

    CrossRef

  13. 13
    Shinsuke Koike, Sosei Yamaguchi, Yasutaka Ojio, Takafumi Shimada, Kei-ichiro Watanabe, Shuntaro Ando, Long-term effect of a name change for schizophrenia on reducing stigma, Social Psychiatry and Psychiatric Epidemiology, 2015, 50, 10, 1519

    CrossRef

  14. 14
    N. Ellison, O. Mason, K. Scior, Renaming schizophrenia to reduce stigma: comparison with the case of bipolar disorder, The British Journal of Psychiatry, 2015, 206, 4, 341

    CrossRef

  15. 15
    Klaas Arts, Secundaire psychosen bij behandelbare neurologische aandoeningen, Tijdschrift voor Neuropsychiatrie en Gedragsneurologie, 2015, 3, 1, 17

    CrossRef

  16. 16
    Antonio Lasalvia, Elena Penta, Norman Sartorius, Scott Henderson, Should the label "schizophrenia" be abandoned?, Schizophrenia Research, 2015, 162, 1-3, 276

    CrossRef

  17. 17
    M. Moutoussis, G. W. Story, R. J. Dolan, The computational psychiatry of reward: broken brains or misguided minds?, Frontiers in Psychology, 2015, 6,

    CrossRef

  18. 18
    Ciarán O'Driscoll, Jennifer Laing, Oliver Mason, Cognitive emotion regulation strategies, alexithymia and dissociation in schizophrenia, a review and meta-analysis, Clinical Psychology Review, 2014, 34, 6, 482

    CrossRef

  19. 19
    M. Markota, J. Sin, H. Pantazopoulos, R. Jonilionis, S. Berretta, Reduced Dopamine Transporter Expression in the Amygdala of Subjects Diagnosed With Schizophrenia, Schizophrenia Bulletin, 2014, 40, 5, 984

    CrossRef

  20. 20
    Toshimasa Maruta, Umberto Volpe, Wolfgang Gaebel, Chihiro Matsumoto, Makio Iimori, Should schizophrenia still be named so?, Schizophrenia Research, 2014, 152, 1, 305

    CrossRef

  21. 21
    Elizabeth Ann Maynard, The diagnostic and statistical manual: sacred text for a secular community?, Mental Health, Religion & Culture, 2014, 17, 2, 136

    CrossRef

  22. 22
    T. P. Freeman, J. M. Stone, B. Orgaz, L. A. Noronha, S. L. Minchin, H. V. Curran, Tobacco smoking in schizophrenia: investigating the role of incentive salience, Psychological Medicine, 2014, 44, 10, 2189

    CrossRef

  23. 23
    C Barkus, D J Sanderson, J N P Rawlins, M E Walton, P J Harrison, D M Bannerman, What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit, Molecular Psychiatry, 2014, 19, 10, 1060

    CrossRef

  24. 24
    BILL GEORGE, AADT KLIJN, A modern name for schizophrenia (PSS) would diminish self-stigma, Psychological Medicine, 2013, 43, 07, 1555

    CrossRef

  25. 25
    Guillermo Lahera, Namdev Freund, Jerónimo Sáiz-Ruiz, Asignación de relevancia (salience) y desregulación del sistema dopaminérgico, Revista de Psiquiatría y Salud Mental, 2013, 6, 1, 45

    CrossRef

  26. 26
    Zsolt Balog, Zsuzsanna Somlai, Szabolcs Kéri, Aversive conditioning, schizotypy, and affective temperament in the framework of the salience hypothesis, Personality and Individual Differences, 2013, 54, 1, 109

    CrossRef

  27. 27
    N. Okkels, D. L. Vernal, S. O. W. Jensen, J. J. McGrath, R. E. Nielsen, Changes in the diagnosed incidence of early onset schizophrenia over four decades, Acta Psychiatrica Scandinavica, 2013, 127, 1
  28. 28
    D. Kingdon, L. Taylor, K. Ma, Y. Kinoshita, Changing name: changing prospects for psychosis, Epidemiology and Psychiatric Sciences, 2013, 22, 04, 297

    CrossRef

  29. 29
    Zerlina Wong, Dost Öngür, Bruce Cohen, Caitlin Ravichandran, Gil Noam, Beth Murphy, Command hallucinations and clinical characteristics of suicidality in patients with psychotic spectrum disorders, Comprehensive Psychiatry, 2013, 54, 6, 611

    CrossRef

  30. 30
    BILL GEORGE, AADT KLIJN, Letter to the Editor: A sweeter smelling rose: a reply to our commentators, Psychological Medicine, 2013, 43, 09, 2015

    CrossRef

  31. 31
    P. Fusar-Poli, J. Van Os, Lost in transition: setting the psychosis threshold in prodromal research, Acta Psychiatrica Scandinavica, 2013, 127, 3
  32. 32
    M.S. Keshavan, R. Tandon, H.A. Nasrallah, Renaming schizophrenia: Keeping up with the facts, Schizophrenia Research, 2013, 148, 1-3, 1

    CrossRef

  33. 33
    Guillermo Lahera, Namdev Freund, Jerónimo Sáiz-Ruiz, Salience and dysregulation of the dopaminergic system, Revista de Psiquiatría y Salud Mental (English Edition), 2013, 6, 1, 45

    CrossRef

  34. 34
    Michael S. Ritsner, Maria Mar, Marina Arbitman, Alexander Grinshpoon, Symptom severity scale of the DSM5 for schizophrenia, and other psychotic disorders: diagnostic validity and clinical feasibility, Psychiatry Research, 2013, 208, 1, 1

    CrossRef

  35. 35
    Michael Kavanagh, Philip Banyard, The Effect of an Alternative Term for Schizophrenia in Reducing Discriminatory Attitudes of the English-Speaking Lay Public, International Journal of Mental Health, 2013, 42, 4, 3

    CrossRef

  36. 36
    A. Lasalvia, M. Tansella, What is in a name? Renaming schizophrenia as a starting point for moving ahead with its re-conceptualization, Epidemiology and Psychiatric Sciences, 2013, 22, 04, 285

    CrossRef

  37. 37
    RICHARD P. BENTALL, Would a rose, by any other name, smell sweeter?, Psychological Medicine, 2013, 43, 07, 1560

    CrossRef

  38. 38
    Ulrich Palm, Centenary of schizophrenia: Should the term survive “togo shicchou sho” and “salience syndrome”?, Asia-Pacific Psychiatry, 2012, 4, 4
  39. 39
    Søren Dinesen Østergaard, Anthony J. Rothschild, Peter Uggerby, Povl Munk-Jørgensen, Per Bech, Ole Mors, Considerations on the ICD-11 Classification of Psychotic Depression, Psychotherapy and Psychosomatics, 2012, 81, 3, 135

    CrossRef

  40. 40
    M. Janssens, T. Lataster, C.J.P. Simons, M. Oorschot, M. Lardinois, J. van Os, I. Myin-Germeys, Emotion recognition in psychosis: No evidence for an association with real world social functioning, Schizophrenia Research, 2012, 142, 1-3, 116

    CrossRef

  41. 41
    I. M. A. Kramer, C. J. P. Simons, I. Myin-Germeys, N. Jacobs, C. Derom, E. Thiery, J. van Os, M. Wichers, Evidence that genes for depression impact on the pathway from trauma to psychotic-like symptoms by occasioning emotional dysregulation, Psychological Medicine, 2012, 42, 02, 283

    CrossRef

  42. 42
    P. Tyrer, From the Editor's desk, The British Journal of Psychiatry, 2012, 200, 4, 352

    CrossRef

  43. 43
    Cagri Yüksel, Julie McCarthy, Ann Shinn, Danielle L. Pfaff, Justin T. Baker, Stephan Heckers, Perry Renshaw, Dost Öngür, Gray matter volume in schizophrenia and bipolar disorder with psychotic features, Schizophrenia Research, 2012, 138, 2-3, 177

    CrossRef

  44. 44
    Schizophrenie –mehr als nur eine „Störung der Einheit des Selbst“, Der Nervenarzt, 2012, 83, 3, 387

    CrossRef

  45. 45
    J. Englebert, Sur le fonctionnement psychologique pervers, Annales Médico-psychologiques, revue psychiatrique, 2012, 170, 8, 547

    CrossRef

  46. 46
    L. Boyer, D. Dassa, J.-C. Samuelian, C. Lancon, Interrogations autour de la valorisation de l’activité en psychiatrie, L'Encéphale, 2011, 37, 1, 1

    CrossRef

  47. 47
    Jean-Raymond Teyssier, Sylviane Ragot, Jean-Christophe Chauvet-Gélinier, Benoit Trojak, Bernard Bonin, Psychotic features in major depressive disorder are not associated with changes in expression of psychosis related genes in the prefrontal cortex, Psychiatry Research, 2011, 186, 1, 156

    CrossRef

  48. 48
    Matcheri S. Keshavan, Henry A. Nasrallah, Rajiv Tandon, Schizophrenia, “Just the Facts” 6. Moving ahead with the schizophrenia concept: From the elephant to the mouse, Schizophrenia Research, 2011, 127, 1-3, 3

    CrossRef

  49. 49
    Stefan Kaiser, Karsten Heekeren, Joe J. Simon, The Negative Symptoms of Schizophrenia: Category or Continuum?, Psychopathology, 2011, 44, 6, 345

    CrossRef

  50. 50
    Nikie Korver-Nieberg, Piotr J. Quee, Heleen B. Boos, Claudia J. Simons, The validity of the DSM-IV diagnostic classification system of non-affective psychoses, Australian and New Zealand Journal of Psychiatry, 2011, 45, 12, 1061

    CrossRef

  51. 51
    Paul Brown, Time engineering in the schizophrenias, Consciousness and Cognition, 2011, 20, 4, 1055

    CrossRef

  52. 52
    Tilman Steinert, Martin Jandl, Are antipsychotics antipsychotics?, Psychopharmacology, 2010, 212, 1, 117

    CrossRef

  53. 53
    Jim Van Os, Are psychiatric diagnoses of psychosis scientific and useful? The case of schizophrenia, Journal of Mental Health, 2010, 19, 4, 305

    CrossRef

  54. You have free access to this content54
    HEINZ KATSCHNIG, Are psychiatrists an endangered species? Observations on internal and external challenges to the profession, World Psychiatry, 2010, 9, 1
  55. 55
    Vladan Starcevic, Euphemisms, political correctness and the identity of psychiatrists, Australasian Psychiatry, 2010, 18, 2, 181

    CrossRef

  56. 56
    I. V. Vahia, B. W. Palmer, C. Depp, I. Fellows, S. Golshan, H. C. Kraemer, D. V. Jeste, Is late-onset schizophrenia a subtype of schizophrenia?, Acta Psychiatrica Scandinavica, 2010, 122, 5
  57. 57
    Stephan Ruhrmann, Frauke Schultze-Lutter, Joachim Klosterkötter, Probably at-risk, but certainly ill — Advocating the introduction of a psychosis spectrum disorder in DSM-V, Schizophrenia Research, 2010, 120, 1-3, 23

    CrossRef

  58. 58
    Bill George, What's in a name? Client participation, diagnosis and the DSM-5, Journal of Mental Health, 2010, 19, 6, 479

    CrossRef

  59. You have free access to this content59
    NORMAN SARTORIUS, WOLFGANG GAEBEL, HELEN-ROSE CLEVELAND, HEATHER STUART, TSUYOSHI AKIYAMA, JULIO ARBOLEDA-FLÓREZ, ANJA E. BAUMANN, OYE GUREJE, MIGUEL R. JORGE, MARIANNE KASTRUP, YURIKO SUZUKI, ALLAN TASMAN, WPA guidance on how to combat stigmatization of psychiatry and psychiatrists, World Psychiatry, 2010, 9, 3